Literature DB >> 19219028

Gene silencing by synthetic U1 adaptors.

Rafal Goraczniak1, Mark A Behlke, Samuel I Gunderson.   

Abstract

We describe a gene silencing method that employs a mechanism of action distinct from those of antisense and RNA interference. U1 Adaptors are bifunctional oligonucleotides with a 'target domain' complementary to a site in the target gene's terminal exon and a 'U1 domain' that binds to the U1 small nuclear RNA component of the U1 small nuclear ribonucleoprotein (U1 snRNP) splicing factor. Tethering of U1 snRNP to the target pre-mRNA inhibits poly(A)-tail addition, causing degradation of that RNA species in the nucleus. U1 Adaptors can inhibit both endogenous and reporter genes in a sequence-specific manner. Comparison of U1 Adaptors with small interfering RNA (siRNA) using a genome-wide microarray analysis indicates that U1 Adaptors have limited off-target effects and no detectable adverse effects on splicing. Further, targeting the same gene either with multiple U1 Adaptors or with a U1 Adaptor and siRNA strongly enhances gene silencing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219028     DOI: 10.1038/nbt.1525

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  36 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Identification of new poly(A) polymerase-inhibitory proteins capable of regulating pre-mRNA polyadenylation.

Authors:  Bom Ko; Samuel I Gunderson
Journal:  J Mol Biol       Date:  2002-05-17       Impact factor: 5.469

Review 3.  Strategies for silencing human disease using RNA interference.

Authors:  Daniel H Kim; John J Rossi
Journal:  Nat Rev Genet       Date:  2007-03       Impact factor: 53.242

4.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

Review 5.  Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.

Authors:  Daniel De Paula; M Vitória L B Bentley; Ram I Mahato
Journal:  RNA       Date:  2007-02-28       Impact factor: 4.942

6.  Design of antisense oligonucleotides stabilized by locked nucleic acids.

Authors:  Jens Kurreck; Eliza Wyszko; Clemens Gillen; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

7.  Characterization of modified antisense oligonucleotides in Xenopus laevis embryos.

Authors:  Kim A Lennox; Jaime L Sabel; Maegan J Johnson; Bernardo G Moreira; Cherisa A Fletcher; Scott D Rose; Mark A Behlke; Andrei L Laikhter; Joseph A Walder; John M Dagle
Journal:  Oligonucleotides       Date:  2006

8.  Functional polarity is introduced by Dicer processing of short substrate RNAs.

Authors:  Scott D Rose; Dong-Ho Kim; Mohammed Amarzguioui; Jeremy D Heidel; Michael A Collingwood; Mark E Davis; John J Rossi; Mark A Behlke
Journal:  Nucleic Acids Res       Date:  2005-07-26       Impact factor: 16.971

9.  Locked nucleic acid (LNA): High affinity targeting of RNA for diagnostics and therapeutics.

Authors:  Sakari Kauppinen; Birte Vester; Jesper Wengel
Journal:  Drug Discov Today Technol       Date:  2005

10.  Inhibiting expression of specific genes in mammalian cells with 5' end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA.

Authors:  Puri Fortes; Yolanda Cuevas; Fei Guan; Peng Liu; Sara Pentlicky; Stephen P Jung; Maria L Martínez-Chantar; Jesús Prieto; David Rowe; Samuel I Gunderson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 12.779

View more
  32 in total

Review 1.  RNAi screening: new approaches, understandings, and organisms.

Authors:  Stephanie E Mohr; Norbert Perrimon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-09-22       Impact factor: 9.957

2.  A splicing component adapted to gene silencing.

Authors:  Xavier Roca; Adrian R Krainer
Journal:  Nat Biotechnol       Date:  2009-03       Impact factor: 54.908

3.  Suboptimal RNA-RNA interaction limits U1 snRNP inhibition of canonical mRNA 3' processing.

Authors:  Junjie Shi; Yanhui Deng; Shanshan Huang; Chunliu Huang; Jinkai Wang; Andy Peng Xiang; Chengguo Yao
Journal:  RNA Biol       Date:  2019-07-07       Impact factor: 4.652

Review 4.  Diverse Applications of Nanomedicine.

Authors:  Beatriz Pelaz; Christoph Alexiou; Ramon A Alvarez-Puebla; Frauke Alves; Anne M Andrews; Sumaira Ashraf; Lajos P Balogh; Laura Ballerini; Alessandra Bestetti; Cornelia Brendel; Susanna Bosi; Monica Carril; Warren C W Chan; Chunying Chen; Xiaodong Chen; Xiaoyuan Chen; Zhen Cheng; Daxiang Cui; Jianzhong Du; Christian Dullin; Alberto Escudero; Neus Feliu; Mingyuan Gao; Michael George; Yury Gogotsi; Arnold Grünweller; Zhongwei Gu; Naomi J Halas; Norbert Hampp; Roland K Hartmann; Mark C Hersam; Patrick Hunziker; Ji Jian; Xingyu Jiang; Philipp Jungebluth; Pranav Kadhiresan; Kazunori Kataoka; Ali Khademhosseini; Jindřich Kopeček; Nicholas A Kotov; Harald F Krug; Dong Soo Lee; Claus-Michael Lehr; Kam W Leong; Xing-Jie Liang; Mei Ling Lim; Luis M Liz-Marzán; Xiaowei Ma; Paolo Macchiarini; Huan Meng; Helmuth Möhwald; Paul Mulvaney; Andre E Nel; Shuming Nie; Peter Nordlander; Teruo Okano; Jose Oliveira; Tai Hyun Park; Reginald M Penner; Maurizio Prato; Victor Puntes; Vincent M Rotello; Amila Samarakoon; Raymond E Schaak; Youqing Shen; Sebastian Sjöqvist; Andre G Skirtach; Mahmoud G Soliman; Molly M Stevens; Hsing-Wen Sung; Ben Zhong Tang; Rainer Tietze; Buddhisha N Udugama; J Scott VanEpps; Tanja Weil; Paul S Weiss; Itamar Willner; Yuzhou Wu; Lily Yang; Zhao Yue; Qian Zhang; Qiang Zhang; Xian-En Zhang; Yuliang Zhao; Xin Zhou; Wolfgang J Parak
Journal:  ACS Nano       Date:  2017-03-14       Impact factor: 15.881

5.  PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.

Authors:  Lucia B Jilaveanu; Fabio Parisi; Meaghan L Barr; Christopher R Zito; William Cruz-Munoz; Robert S Kerbel; David L Rimm; Marcus W Bosenberg; Ruth Halaban; Yuval Kluger; Harriet M Kluger
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

6.  Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy.

Authors:  Lee Spraggon; Luca Cartegni
Journal:  Drug Discov Today Ther Strateg       Date:  2013

7.  U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fate.

Authors:  Jörg Langemeier; Maximilian Radtke; Jens Bohne
Journal:  RNA Biol       Date:  2013-01-16       Impact factor: 4.652

8.  Analysis of human small nucleolar RNAs (snoRNA) and the development of snoRNA modulator of gene expression vectors.

Authors:  Motoharu Ono; Kayo Yamada; Fabio Avolio; Michelle S Scott; Silvana van Koningsbruggen; Geoffrey J Barton; Angus I Lamond
Journal:  Mol Biol Cell       Date:  2010-03-10       Impact factor: 4.138

9.  A complex immunodeficiency is based on U1 snRNP-mediated poly(A) site suppression.

Authors:  Jörg Langemeier; Eva-Maria Schrom; Alona Rabner; Maximilian Radtke; Daniela Zychlinski; Anna Saborowski; Georg Bohn; Yael Mandel-Gutfreund; Jochen Bodem; Christoph Klein; Jens Bohne
Journal:  EMBO J       Date:  2012-09-11       Impact factor: 11.598

10.  Non-coding RNAs: Bridging Biology and Therapy.

Authors:  Daniel P C Shreve; David R F Carter
Journal:  J RNAi Gene Silencing       Date:  2009-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.